Financial News
Charles River Laboratories Intl (NY: CRL )
233.47
+11.66
(+5.26%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 26, 2024
Add to My Watchlist
All News about Charles River Laboratories Intl
![](https://mms.businesswire.com/media/20211111005488/en/926049/5/charles_river_logo.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://g.foolcdn.com/editorial/images/651127/gettyimages-487041721.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_2371.png)
![](https://mms.businesswire.com/media/20211103005133/en/922785/5/charles_river_logo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20211020005110/en/574778/5/charles_river_logo.jpg)
![](https://mms.businesswire.com/media/20211018005603/en/836653/5/charles_river_logo.jpg)
![](https://mms.businesswire.com/media/20211013006051/en/916126/5/charles_river_logo.jpg)
![](https://mms.businesswire.com/media/20211012006071/en/915529/5/charles_river_logo.jpg)
Charles River Laboratories Announces Two Divestitures
October 12, 2021
Via Business Wire
![](https://mms.businesswire.com/media/20210920005309/en/907449/4/5265124_2021_Healthcare_Collaboration_Report_Infographic.jpg)
![](https://mms.businesswire.com/media/20210907005046/en/902831/5/charles_river_logo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://g.foolcdn.com/editorial/images/640154/gettyimages-539000348.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://www.investors.com/wp-content/uploads/2016/06/ibd.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210804005150/en/896015/5/charles_river_logo.jpg)
![](https://mms.businesswire.com/media/20210713005188/en/890821/5/charles_river_logo.jpg)
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_spp_637613666763129178.jpg)
![](https://mms.businesswire.com/media/20210629005177/en/888136/5/charles_river_logo.jpg)
![](https://www.investors.com/wp-content/uploads/2021/06/LSMAIN-river-061121.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://www.investors.com/wp-content/uploads/2019/12/ETFLEADERS-biotech-121319-shutter.jpg)
Exposures
COVID-19
![](https://mms.businesswire.com/media/20210607005238/en/836653/5/charles_river_logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.